(BPTH) - Earnings & Price History

BPTH: - 0.3809, $41.51M, -0.01 (-3.57%)

Sector: Healthcare - Industry: Drug Delivery

Bio-Path Holdings, Inc. operates as a clinical and preclinical stage oncology focused antisense drug development company in the United States. The company develops products based on DNAbilize, a drug delivery and antisense technology that uses P-ethoxy, which is a deoxyribonucleic acid (DNA) backbone modification intended to protect the DNA from destruction. Its lead drug candidate is Liposomal Grb2, which is in Phase II clinical trials for the treatment of acute myeloid leukemia and chronic myelogenous leukemia; and in preclinical studies for solid tumors, including triple negative breast cancer and inflammatory breast cancer. The company is also developing Liposomal Bcl2, which is in Phase I clinical trial for the treatment of lymphoma. It has license agreement with The University of Texas relating to the delivery technology platform for antisense nucleic acids, including two single nu

Past BPTH reports
Earning DateTimeTitleEPS-e EPS-a ClosePrev CloseOpen Day LowDay High Gap % CFO %Change % Volume
2017-03-15BMO-0.030.82960.94010.950.80.951.05%-12.67%-11.75%194.56K
2016-11-10BMO-0.011.241.211.251.151.253.31%▲-0.80%2.48%220.94K
2016-11-09BMO-0.011.211.11.091.091.23-0.91%▲11.01%10.00%142.91K
2016-11-08BMO-0.011.11.111.131.091.131.80%▲-2.65%-0.90%85.59K
2016-08-10BMO-0.021.721.731.671.671.73-3.47%2.99%-0.58%158.75K
2016-08-09BMO-0.021.731.721.731.71.740.58%0.58%83.06K
2016-05-11BMO-0.012.672.752.752.62.75-2.91%-2.91%148.31K
2016-03-16BMO-0.011.861.851.851.771.870.54%0.54%26.68K
2016-03-15-0.011.861.851.851.771.870.54%0.54%26.68K
2015-11-10-0.011.491.481.481.461.520.68%0.68%29.32K
2015-08-11-0.031.181.221.21.151.22-1.64%-1.67%-3.28%79.94K
2015-05-12-0.031.241.121.081.2510.71%193.41K
2015-03-17-0.011.791.791.781.711.81-0.56%0.56%46.77K
2014-11-21Bio-path Hldgs-0.012.62.622.642.582.70.76%▲-1.52%-0.76%83.00K
2014-08-21Bio-path Hldgs-0.012.232.342.322.22.36-0.85%-3.88%-4.70%117.80K
2014-05-15Bio-path Hldgs-0.012.72.72.72.642.7575.80K
2014-04-01Bio-path Hldgs0.012.462.262.32.32.51.77%6.96%8.85%202.50K
2013-11-15Bio-path Hldgs-0.01-0.022.392.012.172.152.397.96%▲10.14%18.91%29.80K
2013-08-15Bio-path Hldgs-0.010.550.520.520.520.555.77%5.77%6.60K
2013-05-16Bio-path Hldgs-0.010.490.540.550.490.551.85%-10.91%-9.26%2.80K
2013-04-09Bio-path Hldgs-0.0100.540.550.550.530.55-1.82%-1.82%9.80K
2012-11-16Bio-path Hldgs-0.010.310.350.310.310.31-11.43%▲-11.43%6.60K
2012-08-16Bio-path Hldgs-0.010.370.360.370.370.372.78%2.78%15.10K
2012-05-17Bio-path Hldgs-0.010.290.340.290.290.29-14.71%-14.71%3.00K
2012-04-05Bio-path Hldgs-0.02-0.010.30.290.30.280.33.45%3.45%71.00K
2011-11-15Bio-path Hldgs-0.02-0.010.30.30.310.30.343.33%▲-3.23%8.80K
2011-08-16Bio-path Hldgs-0.010.410.420.410.370.41-2.38%-2.38%2.40K
2011-05-16Bio-path Hldgs-0.02-0.010.350.370.380.350.382.70%-7.89%-5.41%10.40K
2011-03-08Bio-path Hldgs-0.010.50.510.510.50.51-1.96%-1.96%6.80K

Login | Register
Sunday Oct 21, 2018   EST
Enter a Ticker:

Economic Calendar

AAII Sentiment Survey

BULL^ neut ^ BEAR

Chart

index chart
index color
SPY257.6450.500.19%41,867,194

Upgrades/Downgrades